Negative Symptoms in Schizophrenia

Total Page:16

File Type:pdf, Size:1020Kb

Negative Symptoms in Schizophrenia Reward Processing Mechanisms of Negative Symptoms in Schizophrenia Gregory P. Strauss, Ph.D. Assistant Professor Department of Psychology University of Georgia Disclosures ACKNOWLEDGMENTS & DISCLOSURES ▪ Receive royalties and consultation fees from ProPhase LLC in connection with commercial use of the BNSS and other professional activities; these fees are donated to the Brain and Behavior Research Foundation. ▪ Last 12 Months: Speaking/consultation with Minerva, Lundbeck, Acadia What are negative symptoms and why are they important? Domains of psychopathology in schizophrenia Negative Symptoms ▪ Negative symptoms - reductions in goal-directed activity, social behavior, pleasure, and the outward expression of emotion or speech Cognitive Positive ▪ Long considered a core feature of psychotic disorders1,2 Deficits Symptoms ▪ Distinct from other domains of psychopathology (e.g., psychosis, disorganization) 3 ▪ Associated with a range of poor clinical outcomes (e.g., Disorganized Affective disease liability, quality of life, subjective well-being, Symptoms Symptoms recovery) 4-7 1. Bleuler E. [Dementia praecox or the group of schizophrenias]. Vertex Sep-Oct 2010;21(93):394-400. 2. Kraepelin E. Dementia praecox and paraphrenia (R. M. Barclay, Trans.). New York, NY: Krieger. 1919. 3. Peralta V, Cuesta MJ. How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophrenia research Apr 30 2001;49(3):269-285. 4. Fervaha G, Remington G. Validation of an abbreviated quality of life scale for schizophrenia. Eur Neuropsychopharmacol Sep 2013;23(9):1072-1077. 5. Piskulic D, Addington J, Cadenhead KS, et al. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry research Apr 30 2012;196(2-3):220-224. 6. Strauss GP, Harrow M, Grossman LS, Rosen C. Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study. Schizophrenia bulletin Jul 2010;36(4):788-799. 7. Strauss GP, Sandt AR, Catalano LT, Allen DN. Negative symptoms and depression predict lower psychological well-being in individuals with schizophrenia. Comprehensive psychiatry Nov 2012;53(8):1137-1144. Challenges in Treatment ▪ Psychosocial and pharmacological interventions have yielded limited effectiveness for improving negative symptoms in schizophrenia 8 ▪ No drug has received an indication for negative symptoms from the FDA ▪ 2005 NIMH Consensus Conference 9 ▪ 5 domains: blunted affect, alogia, anhedonia, avolition, asociality ▪ New assessments needed ▪ Need more studies on pathophysiology to identify treatment targets 8. Fusar-Poli P, Papanastasiou E, Stahl D, Rocchetti M, Carpenter W, Shergill S, McGuire P. Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials. Schizophrenia bulletin Jul 2015;41(4):892-899. 9. Kirkpatrick B, Fenton WS, Carpenter WT, Jr., Marder SR. The NIMH-MATRICS consensus statement on negative symptoms. Schizophrenia bulletin Apr 2006;32(2):214-219. Early Identification and Prevention From Addington & Heinssen, 2012 Addington, J., & Heinssen, R. (2012). Prediction and prevention of psychosis in youth at clinical high risk. Annual review of clinical psychology, 8, 269-289. Negative Symptoms Occur Outside of Schizophrenia- we just don’t call them that 1.Schizophrenia 2. Schizoaffective Disorder From Strauss & Cohen, 2017 3. Schizophreniform Disorder 4. Schizotypal Personality Disorder 5. Schizoid Personality Disorder 6. Paranoid Personality Disorder 7. Avoidant Personality Disorder 8. Bipolar Disorder (I and II) 9. Major Depressive Disorder 10. Persistent Depressive Disorder (Dysthymia) 11. Premenstrual Dysphoric Disorder 12. Selective Mutism 13. Social Anxiety Disorder 14. Separation Anxiety Disorder 15. Reactive Attachment Disorder 16. Posttraumatic Stress Disorder 17. Depersonalization/Derealization Disorder 18. Autism Spectrum Disorder 19. Neurocognitive Disorders Strauss, G. P., & Cohen, A. S. (2017). A transdiagnostic review of negative symptom phenomenology and etiology. Schizophrenia bulletin, 43(4), 712-719. How severe are negative symptoms when they occur in the prodrome and outside of schizophrenia? Z-Scores Compared to Healthy Control Group Z-Scores Compared to Schizophrenia Group 6 0 -0.2 5 -0.4 -0.6 4 -0.8 3 -1 -1.2 2 -1.4 1 -1.6 score score Compared to Schizophrenia Group score score Compared to Healthy Control Group - - Z -1.8 Z 0 Blunted Alogia Avolition Anhed/Asoc EXP VOL Total Blunted Affect Alogia Avolition Anhed/Asoc EXP VOL Total Affect Schizoaffective Disorder Major Depressive Disorder Ultra High-Risk Schizophrenia Schizoaffective Disorder Major Depressive Disorder Bipolar Disorder Healthy Control Ultra High-Risk Bipolar Disorder Strauss, G. P., & Cohen, A. S. (2017). A transdiagnostic review of negative symptom phenomenology and etiology. Schizophrenia bulletin, 43(4), 712-719. Strauss et al. JAMA Psychiatry (2019) Which domain(s) should be targeted? Is one domain more central than the others? Control Bipolar Disorder Schizophrenia What was most central? What was most central? What was most central? Anhedonia Anhedonia Avolition, alogia Strauss et al., in press. Schizophr Bulletin Avolition– Key for Functional Outcome Total Social Work Blunted Affect -.43*** -.38*** -.30*** Alogia -.42*** -.39*** -.28*** Anhedonia -.52*** -.44*** -.30*** Avolition -.63*** -.46*** -.51*** Asociality -.62*** -.60*** -.39*** Avolition- the key domain for treatment Data from MIN-101 (Roluperidone) Clinical Trial (Davidson et al., 2017, AJP) Centrality Measures: Key symptom that leads to improvement: AVOLITION INTERNAL EXPERIENCE Strauss et al., in press Schiz Bull Etiological Models of Avolition in Schizophrenia • Several etiological Reward Responsiveness 3. Reward Learning Prediction models have been Error DA, VS, PFC 1. Initial Response 2. Reward Anticipation developed for Opioid & GABA in DA, BG, ACC Implicit Explicit BG, OFC (Gold et al., 2008; DA, BG ACC, OFC, avolition DLPFC Barch & Dowd, 2010; Kring & Ellis, 2013; Strauss et al., 2014; 2017) • The NIMH RDoC “positive valence 4. Delay 5. Effort system” offers a OFC DA, VS, ACC useful conceptual Reward Valuation framework Modified from Barch & Dowd, 2010 Motivated Behavior Barch, D. M., & Dowd, E. C. (2010). Goal representations and motivational drive in schizophrenia: the role of prefrontal– striatal interactions. Schizophrenia bulletin, 36(5), 919-934. Summary Construct/Sub-construct Mechanism Mood Schizophrenia Clinical High-Risk Reward Responsiveness Initial Response Opioid & GABA Impaired Intact Impaired in BG, OFC Anticipation DA; BG & ACC Impaired Impaired Impaired Reward Learning Reinforcement Learning Implicit DA; BG Impaired Intact Impaired Reinforcement Learning Explicit DA; ACC; OFC, Intact Impaired Impaired DLPFC Reward Prediction Error DA, 5HT; BG, Impaired Intact* Impaired ACC, OFC Reward Valuation Delay OFC, MPFC, BG Impaired Impaired Impaired Effort DA, GABA; BG, Impaired Impaired Impaired ACC, Amygdala For transdiagnostic reviews see Strauss & Cohen, 2019; Barch et al., 2019 How inter-connected are the domains? If you target reward processing broadly, will all reward domains be expected to improve? SZ vs. CN Strauss et al., under review 3.40 SZ: n = 54 3.50 2.79 CN: n = 54 3.00 2.50 2.00 0.88 1.50 0.78 0.72 0.59 1.00 0.50 0.00 Avg. Clustering Avg. Shortest Path Density Coefficient Length Group SZ Group CN SZ vs. SZ Affective Diagnosis SZ Neg. High vs. Neg Low 3.00 2.44 2.51 2.48 3.00 2.52 2.50 2.00 2.00 1.50 0.92 0.90 0.89 0.89 0.81 0.79 0.82 0.80 1.00 1.00 0.50 0.00 Avg. Clustering Avg. Shortest Path Density 0.00 Coefficient Length Avg. Clustering Avg. Shortest Path Density Coefficient Length High Negative Low Negative SZ SZOA Is one reward processing domain more central than the others and thus a more critical target? Strauss et al., in prep SZ: n = 54 CN: n = 54 Is it possible to stratify patients into clinically meaningful subgroups based on reward processing task performance? 3 Clusters 1.00 • Cluster 1: Global reward processing impairment (9%) 0.00 • Cluster 2: Hedonic and effort impairment (66%) • Cluster 3: Intact reward processing (25%) -1.00 -2.00 score - Z -3.00 -4.00 Strauss et al., in prep -5.00 SZ: n = 54 Hedonic ValueRep Effort RewLearn CHR: n = 68 Cluster 1 Cluster 2 Cluster 3 CN: n = 112 9% 66% 25% Do the reward-based subgroups differ on external validators? Diagnoses Cluster 1 Cluster 2 Cluster 3 • Cluster 1: Global reward processing impairment (9%) % SZ 100% 59% 38.5% • Cluster 2: Hedonic and effort impairment (66%) • Cluster 3: Intact reward processing (25%) % CHR 0% 41% 61.5% Clinical Characteristics Cluster 1 Cluster 2 Cluster 3 Post hoc BNSS Avolition 4.4 (2.7) 3.4 (3.1) 2.8 (3.0)* 1>3 BNSS Anhedonia 4.8 (3.5) 4.1 (3.8) 3.7 (4.7)* 1>3 BNSS Asociality 3.4 (2.8) 2.4 (2.5) 1.8 (2.4) n.s. BNSS Alogia 0.4 (0.8) 0.9 (2.1) 0.4 (0.7) n.s. BNSS Blunted Affect 0.3 (0.5) 2.5 (3.6) 1.3 (2.1) n.s. EMA % Goal-Directed Time 34% (31) 43% (23) 45% (22)* 1<2,3 Geolocation % Home Time 64% (13) 58% (31) 55% (31)* 1>2,3 Strauss et al., in prep Ambient Sound Speech Detected 43 (21) 47 (75) 162 (37)* 3>1,2 SZ: n = 54 CHR: n = 68 MATRICS Global Cognition 27 (19) 43 (14) 48 (12)* 1<2,3 CN: n = 112 Equifinality within reward domains in SZ? Cooper, J. A., Barch, D. M., Reddy, L. F., Horan, W. P., Green, M. F., & Treadway, M. T. (2019). Effortful goal-directed behavior in schizophrenia: Computational subtypes and associations with cognition. Journal of abnormal psychology, 128(7), 710. Literature Summary • Avolition
Recommended publications
  • Autism Spectrum Disorders Among Adolescents and Adults and Comparison with Schizophrenia
    The European Research Journal 2019;5(6):962-968 ORIGINAL ARTICLE Autism spectrum disorders among adolescents and adults and comparison with schizophrenia Aylin Küçük1 , Fulya Maner2 , Mehmet Emin Ceylan3 1Department of Psychiatry, Adana City Training and Research Hospital, Adana, Turkey 2Department of Child Development, Kırklareli University, Kırklareli, Turkey 3Deparment Of Psychology, Üsküdar Üniversty, İstanbul, Turkey DOI: 10.18621/eurj.441214 ABSTRACT Objectives: Autism Spectrum Disorders (ASD) may be commonly misdiagnosed as schizophrenia due to common symptoms and accompanying psychotic manifestations in both adolescence and adulthood. The purpose of this study is to examine and compare the autistic symptoms and positive and negative symptoms of schizophrenia in cases diagnosed as Autism Spectrum Disorder. Methods: Twenty-one patients between ages of 16-36 who have admitted to outpatient clinic have previously been diagnosed as autism spectrum disorders (autistic disorder, Asperger Syndrome, pervasive development disorder not otherwise specified) according to DSM-IV diagnosis criteria, have an IQ of 50 or above, have been included in the study. Control group have been composed of 21 patients between ages of 21-39 who have been diagnosed as schizophrenia according to DSM-IV diagnosis criteria and have an IQ of 50 or above. Psychiatric assessment has been made with Childhood Autism Rating Scale (CARS), Scale for the Assessment of Positive Symptoms (SAPS), Scale for the Assessment of Negative Symptoms (SANS), SCID-I and WAIS. Results: The negative symptoms of ASD are found to be higher than schizophrenia cases where as the positive symptoms of schizophrenia cases are found to be higher than ASD cases. Twenty percent (n = 4) of OSB cases do not meet autism symptoms while none of the schizophrenia cases meet autism symptoms.
    [Show full text]
  • The Latent Structure of Negative Symptoms in Schizophrenia
    Supplementary Online Content Strauss GP, Nuñez A, Ahmed AO, et al. The latent structure of negative symptoms in schizophrenia. JAMA Psychiatry. Published online September 12, 2018. doi:10.1001/ jamapsychiatry.2018.2475 eTable 1. Confirmatory Factor Analysis Models for the Scale for the Assessment of Negative Symptoms (SANS) eTable 2. Confirmatory Factor Analysis Models for the Brief Negative Symptom Scale (BNSS) eTable 3. Confirmatory Factor Analysis Models for the Clinical Assessment Interview for Negative Symptoms (CAINS) This supplementary material has been provided by the authors to give readers additional information about their work. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/02/2021 eTable 1. Confirmatory Factor Analysis Models for the Scale for the Assessment of Negative Symptoms (SANS) SANS Items and Domains Mean SD Range CFA Models UNI MAP/EXP Consensus Consensus HM 1st 2nd order order Anhedonia 15. Anhedonia 1.7 1.3 0-5 1 1 1 1 1 Asociality 14. Asociality 2.2 1.3 0-5 1 1 2 2 1 16. Decreased Sex. 2.7 1.7 0-5 1 1 2 2 1 Interest/Activity 17. Ability Feel 1.9 1.3 0-5 1 1 2 2 1 Intimacy/Closeness Avolition-Apathy 10. Grooming and 1.1 1.2 0-5 1 1 3 3 1 Hygiene 11. Current Role 3.6 1.6 0-5 1 1 3 3 1 Function - Level 12. Current Role 1.9 2.1 0-5 1 1 3 3 1 Function – Quality 13. Physical Anergia 2.4 1.4 0-5 1 1 3 3 1 Affective Flattening/Blunting 1.
    [Show full text]
  • Neurophysiological Correlates of Avolition-Apathy in Schizophrenia: a Resting-EEG Microstates Study T ⁎ Giulia M
    NeuroImage: Clinical 20 (2018) 627–636 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study T ⁎ Giulia M. Giordanoa,1, Thomas Koenigb,1, Armida Muccia, , Annarita Vignapianoa, Antonella Amodioa, Giorgio Di Lorenzoc, Alberto Siracusanoc, Antonello Bellomod, Mario Altamurad, Palmiero Monteleonee, Maurizio Pompilif, Silvana Galderisia, Mario Maja, The add-on EEG study of the Italian Network for Research on Psychoses2 a Department of Psychiatry, University of Campania “Luigi Vanvitelli”, Naples, Italy b Translational Research Center, University Hospital of Psychiatry, University of Bern, Bern, Switzerland c Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy d Department of Clinical and Experimental Medicine, Psychiatry Unit, University of Foggia, Foggia, Italy e Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, Section of Neurosciences, University of Salerno, Salerno, Italy f Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Center, Sant' Andrea Hospital, Sapienza University of Rome, Rome ARTICLE INFO ABSTRACT Keywords: Background: The “Avolition-apathy” domain of the negative symptoms was found to include different symptoms Schizophrenia by factor analytic studies on ratings derived by different scales. In particular, the relationship of anhedonia with Avolition-apathy this domain is controversial. Recently introduced negative symptom rating scales provide a better assessment of Anhedonia anhedonia, allowing the distinction of anticipatory and consummatory aspects, which might be related to dif- Resting-EEG ferent psychopathological dimensions. The study of associations with external validators, such as electro- Brain electrical microstates physiological, brain imaging or cognitive indices, might shed further light on the status of anhedonia within the Avolition-apathy domain.
    [Show full text]
  • Sex Differences in Symptom Presentation of Schizotypal
    Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Psychology Dissertations Student Dissertations, Theses and Papers 2009 Sex Differences in Symptom Presentation of Schizotypal Personality Disorder in First-Degree Family Members of Individuals with Schizophrenia Alexandra Duncan-Ramos Philadelphia College of Osteopathic Medicine, [email protected] Follow this and additional works at: http://digitalcommons.pcom.edu/psychology_dissertations Part of the Clinical Psychology Commons Recommended Citation Duncan-Ramos, Alexandra, "Sex Differences in Symptom Presentation of Schizotypal Personality Disorder in First-Degree Family Members of Individuals with Schizophrenia" (2009). PCOM Psychology Dissertations. Paper 40. This Dissertation is brought to you for free and open access by the Student Dissertations, Theses and Papers at DigitalCommons@PCOM. It has been accepted for inclusion in PCOM Psychology Dissertations by an authorized administrator of DigitalCommons@PCOM. For more information, please contact [email protected]. Philadelphia College of Osteopathic Medicine Department of Psychology SEX DIFFERENCES IN SYMPTOM PRESENTATION OF SCHIZOTYPAL PERSONALITY DISORDER IN FIRST-DEGREE FAMILY MEMBERS OF INDIVIDUALS WITH SCHIZOPHRENIA By Alexandra Duncan-Ramos, M.S., M.S. Submitted in Partial Fulfillment of the Requirements of the Degree of Doctor of Psychology July 2009 PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE DEPARTMENT OF PSYCHOLOGY Dissertation Approval This is to certify that the thesis presented to us by Alexandra Duncan-Ramos on the 23rd day of July, 2009 in partial fulfillment of the requirements for the degree of Doctor of Psychology, has been examined and is acceptable in both scholarship and literary quality. Committee Members' Signatures: Barbara Golden, Psy.D., ABPP, Chairperson Brad Rosenfield, Psy.D. Monica E. Calkins, Ph.D.
    [Show full text]
  • The Clinical Presentation of Psychotic Disorders Bob Boland MD Slide 1
    The Clinical Presentation of Psychotic Disorders Bob Boland MD Slide 1 Psychotic Disorders Slide 2 As with all the disorders, it is preferable to pick Archetype one “archetypal” disorder for the category of • Schizophrenia disorder, understand it well, and then know the others as they compare. For the psychotic disorders, the diagnosis we will concentrate on will be Schizophrenia. Slide 3 A good way to organize discussions of Phenomenology phenomenology is by using the same structure • The mental status exam as the mental status examination. – Appearance –Mood – Thought – Cognition – Judgment and Insight Clinical Presentation of Psychotic Disorders. Slide 4 Motor disturbances include disorders of Appearance mobility, activity and volition. Catatonic – Motor disturbances • Catatonia stupor is a state in which patients are •Stereotypy • Mannerisms immobile, mute, yet conscious. They exhibit – Behavioral problems •Hygiene waxy flexibility, or assumption of bizarre • Social functioning – “Soft signs” postures as most dramatic example. Catatonic excitement is uncontrolled and aimless motor activity. It is important to differentiate from substance-induced movement disorders, such as extrapyramidal symptoms and tardive dyskinesia. Slide 5 Disorders of behavior may involve Appearance deterioration of social functioning-- social • Behavioral Problems • Social functioning withdrawal, self neglect, neglect of • Other – Ex. Neuro soft signs environment (deterioration of housing, etc.), or socially inappropriate behaviors (talking to themselves in
    [Show full text]
  • Living with Serious Mental Illness: the Role of Personal Loss in Recovery and Quality of Life
    LIVING WITH SERIOUS MENTAL ILLNESS: THE ROLE OF PERSONAL LOSS IN RECOVERY AND QUALITY OF LIFE Danielle Nicole Potokar A Dissertation Submitted to the Graduate College of Bowling Green State University in partial fulfillment of the requirements for the degree of: DOCTOR OF PHILOSOPHY December 2008 Committee: Catherine Stein, Ph.D., Advisor Alexander Goberman, Ph.D., Graduate Faculty Representative Dryw Dworsky, Ph.D. Jennifer Gillespie, Ph.D. © 2008 Danielle Nicole Potokar All Rights Reserved iii ABSTRACT Catherine Stein, Ph.D., Advisor As the mental health field is moving towards a recovery based model of serious mental illness for both conceptualization and treatment, further research into the factors which may impact recovery and quality of life are needed. Currently, there are no studies which examine how personal loss due to mental illness or cognitive insight relate to factors such as quality of life and recovery. The purpose of the present study was to investigate the relative contribution of demographic factors, self-reports of psychiatric symptoms, and individual factors of cognitive insight and personal loss in describing variation in reports of quality of life and recovery from mental illness. It was hypothesized that cognitive insight and personal loss would each predict a significant portion of the variance in scores of quality of life and recovery from mental illness. A sample of 65 veterans with serious mental illness from the Minneapolis Veterans Affairs Medical Center completed structured interviews regarding psychiatric symptomotology and quality of life and completed questionnaires related to demographics, cognitive insight, personal loss due to mental illness, and recovery. Thirteen significant hierarchical regression models emerged.
    [Show full text]
  • Introduction to Agitation, Delirium, and Psychosis Curriculum for Psychologists/Social Workers
    FACILITATOR MANUAL ENGLISH-HAITI Introduction to Agitation, Delirium, and Psychosis Curriculum for Psychologists/Social Workers Introduction to Agitation, Delirium, and Psychosis Curriculum for Psychologists/Social Workers Partners In Health (PIH) is an independent, non-profit organization founded over twenty years ago in Haiti with a mission to provide the very best medical care in places that had none, to accompany patients through their care and treatment, and to address the root causes of their illness. Today, PIH works in fourteen countries with a comprehensive approach to breaking the cycle of poverty and disease — through direct health-care delivery as well as community-based interventions in agriculture and nutrition, housing, clean water, and income generation. PIH’s work begins with caring for and treating patients, but it extends far beyond to the transformation of communities, health systems, and global health policy. PIH has built and sustained this integrated approach in the midst of tragedies like the devastating earthquake in Haiti. Through collaboration with leading medical and academic institutions like Harvard Medical School and the Brigham & Women’s Hospital, PIH works to disseminate this model to others. Through advocacy efforts aimed at global health funders and policymakers, PIH seeks to raise the standard for what is possible in the delivery of health care in the poorest corners of the world. PIH works in Haiti, Russia, Peru, Rwanda, Sierra Leone, Liberia Lesotho, Malawi, Kazakhstan, Mexico and the United States. For more information about PIH, please visit www.pih.org. Many PIH and Zanmi Lasante staff members and external partners contributed to the development of this training.
    [Show full text]
  • Cognitive Behavioural Therapy (CBT) for Schizophrenia: a Meta-Analysis
    Running head: COGNITIVE BEHAVIOURAL THERAPY (CBT) FOR SCHIZOPRENIA Cognitive Behavioural Therapy (CBT) for Schizophrenia: A Meta-Analysis Gemma Holton BA (Hons) A report submitted in partial requirement for the degree of Master of Psychology (Clinical) at the University of Tasmania October 2015 COGNITIVE BEHAVIOURAL THERAPY (CBT) FOR SCHIZOPHRENIA I declare that this research report is my own work, and that, to the best of my knowledge and belief, it does not contain material from published sources without acknowledgement, nor does it contain material which has been accepted for the award for any other higher degree or graduate diploma in any university. Gemma Holton ii COGNITIVE BEHAVIOURAL THERAPY (CBT) FOR SCHIZOPHRENIA Acknowledgements I wish to express my thanks to my supervisor Dr Bethany Wootton for her considerate support throughout this project. I am extremely grateful for all the practical advice and continual support and encouragement she gave. Dr Wootton encouraged me to complete my thesis in an area of my interest and never expressed any doubt in my ability. Her methodical and consistent approach, patience and valuable advice are truly appreciated. I thank the staff of RFT who understood my vision when I informed them I was returning to university to complete my Masters in clinical psychology. RFT have been immensely supportive throughout this degree, encouraging me to achieve and share my knowledge, and share my valuable time. To my family and friends, I would like to say a big thank you for encouraging me to return to university and finish what I began. Thank you for supporting me and understanding how much time was dedicated to completing my studies.
    [Show full text]
  • Schizophrenia- What You Need to Know
    SCHIZOPHRENIA- WHAT YOU NEED TO KNOW BY CATHY CYWINSKI, MSW LCSW SIGNS AND SYMPTOMS OF SCHIZOPHRENIA • Hallucinations- false perception • Delusions –fixed false belief • Grossly Disorganized Speech and Behavior • Tend to dress and act in odd ways • Flat Affect SYMPTOMS • Hallucinations-can occur with any of the five senses: • Auditory hallucinations • Visual hallucinations • Tactile hallucinations • Olfactory hallucinations • Gustatory hallucinations SYMPTOMS • Bizarre delusion – this simply translated means a delusion regarding something that CANNOT possibly happen. • Nonbizarre delusion – this is a delusion regarding something that CAN possibly happen. COMMON TYPES OF DELUSIONS • Grandiose • Erotomanic • Religious • Delusions of Control • Persecutory • Referential SYMPTOMS • Disorganized Speech • Loose associations- may go from one topic to another with no clear logic • Tangentiality- answers to questions may be obliquely related or completely unrelated • Incoherence or word salad- speech may be so severely disorganized that it is nearly incomprehensible SYMPTOMS • Grossly disorganized behavior • A person may appear disheveled, may dress in an unusual manner (many layers of clothes on a hot day), or may display inappropriate sexual behavior. • Alogia-poverty of speech- brief, empty replies • Avolition- inability to initiate and persist in goal directed activates. The person may sit for long periods of time and show little interest in participating in work or social activities. • Catatonic motor behaviors- a marked decrease in reactivity to the environments. SYMPTOMS • Negative Symptoms • Affect flattening- a person’s face appearing immobile and unresponsive, with poor eye contact and reduced body language IS THERE SOMETHING TO FEAR • Myth: People with a severe mental illness are violent and unpredictable. • Fact: The vast majority of people with mental health problems are no more likely to be violent than anyone else.
    [Show full text]
  • Running Head: AUTISM SPECTRUM DISORDER and SCHIZOPHRENIA 1
    Running head: AUTISM SPECTRUM DISORDER AND SCHIZOPHRENIA 1 Autism Spectrum Disorder and Schizophrenia A Literature Review Presented to The Faculty of the Adler Graduate School ____________________ In Partial Fulfillment of the Requirement for The Degree of Master of Arts in Adlerian Counseling and Psychotherapy ____________________ By Björn Walter ____________________ Chair: Richard Close, DMin, LPCC, LMFT Reader: Meghan Williams, MA, LMFT ____________________ August, 2017 AUTISM SPECTRUM DISORDER AND SCHIZOPHRENIA 2 Abstract This literature review sets out to compare the similarities and the differences between autism spectrum disorder and schizophrenia. To understand the relationship between the two disorders, this project includes an examination of the historical timeline, an analysis of the diagnostic criteria, the impact and effectiveness of various treatments for autism spectrum disorder and schizophrenia. Emphasis is on Adlerian therapy, pharmacological treatment through antipsychotic medications, and the legal and ethical issues as a result of misdiagnosis. To achieve understanding around ethical and legal concerns regarding misdiagnosis, this project includes a hypothetical case study to demonstrate potential harm after the wrong treatment. The primary purpose of this paper is to increase awareness of the problematic situations that arise when the autism spectrum disorder and schizophrenia are misdiagnosed. Keywords: autism spectrum disorder, schizophrenia, Adlerian therapy, antipsychotic medication, DSM-5 AUTISM SPECTRUM DISORDER AND SCHIZOPHRENIA 3 Acknowledgements I would first like to thank my colleagues at the Autism Society of Minnesota. I would like to particularly extend my gratitude to Dr. Barbara Luskin. You inspired me to complete this project, and I will always be grateful for the support you gave me. I would also like to thank my family for always being there for me.
    [Show full text]
  • Distinct Effects of Social Motivation on Face Evaluations in Adolescents
    www.nature.com/scientificreports Corrected: Author Correction OPEN Distinct efects of social motivation on face evaluations in adolescents with and without autism Received: 5 October 2017 Lou Safra 1, Christina Ioannou1, Frédérique Amsellem2,3, Richard Delorme2,3 & Accepted: 21 June 2018 Coralie Chevallier1 Published online: 13 July 2018 Individual diferences in social motivation have an infuence on many behaviours in both clinical and non-clinical populations. As such, social motivation has been identifed as a biological trait that is particularly well-suited for dimensional approaches cutting across neuropsychological conditions. In the present paper, we tested whether social motivation had a similar impact in the general population and in a neuropsychological condition characterized by diminished social motivation: Autism Spectrum Disorders (ASD). More precisely, we evaluated the efect of social motivation on face evaluations in 20 adolescents with ASD and 20 matched controls using avatars parametrically varying in dominance and trustworthiness. In line with previous research, we found in the control group that participants with higher levels of social motivation relied more on perceived trustworthiness when producing likeability judgments. However, this pattern was not found in the ASD group. Social motivation thus appears to have a diferent efect in ASD and control populations, which raises questions about the relevance of subclinical or non-clinical populations to understand ASD. Compared to many other animals, humans stand out when it comes to the variety of social interactions they pursue and the importance of social activities in their ecological niche1. Te willingness to be included in social interactions and the propensity to preferentially attend to the social world is present early on in development and remains a driving force throughout the lifespan2–4.
    [Show full text]
  • The Differential Diagnosis of Excessive Daytime Sleepiness And
    Case Reports The Differential Diagnosis of Excessive Daytime Sleepiness and Cognitive Deficits in a Patient with Delirium, Schizophrenia and Possible Narcolepsy: A Case Report David R. Spiegel 1, Parker W. Babington 1, Ariane M. Abcarian 1, Christian De Filippo 1 Abstract Narcolepsy and schizophrenia are disorders which share common features of negative symptoms, excessive daytime sleepiness and cognitive deficits. Presented here is a case report of a fifty-nine year old man with a past medical history of schizophrenia who was evaluated for suspected symptoms of delirium. After an electroencephalogram was per- formed with surprising results, the patient’s differential diagnosis included schizophrenia with comorbid narcolepsy. We present emerging evidence that excessive daytime sleepiness and attentional deficits in both narcolepsy and schizo- phrenia may share a common pathophysiological pathway through orexin deficiency and its effects on the dopamine system. Finally, we discuss the potential for modafinil as a treatment for excessive daytime sleepiness and attentional problems in schizophrenia and narcolepsy. Key Words: Cognition, Schizophrenia, Sedation, Sleep, Dopamine Introduction The hallmarks of delirium as described by the Diagnostic including the positive symptoms of delusions, hallucina- and Statistical Manual of Mental Disorders, Fourth Edition, tions, disorganized speech and grossly disorganized or cata- Text Revision (DSM-IV-TR) are a disturbance of conscious- tonic behavior, and negative symptoms such as flattened af- ness with reduced ability to focus, sustain or shift attention. fect, alogia and avolition (1). Patients with schizophrenia Also present is a change in cognition, such as memory defi- also have cognitive deficits, including poor attention span. cit, disorientation or language impairment, or a perceptual Rapid eye movement (REM) sleep onset disorders such disturbance.
    [Show full text]